{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:24:41Z","timestamp":1788222281477,"version":"build-2803163510"},"reference-count":49,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["TCS\/21\/25"],"award-info":[{"award-number":["TCS\/21\/25"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]},{"name":"la Asociaci\u00f3n Espa\u00f1ola Contra","award":["HUNTER"],"award-info":[{"award-number":["HUNTER"]}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC","doi-asserted-by":"crossref","award":["HUNTER"],"award-info":[{"award-number":["HUNTER"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC","doi-asserted-by":"crossref","award":["IG AIRC 2019, ID 23408"],"award-info":[{"award-number":["IG AIRC 2019, ID 23408"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Samuel Waxman Cancer Research Foundation, EIT","award":["18053"],"award-info":[{"award-number":["18053"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01619"],"award-info":[{"award-number":["PI21\/01619"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Welcome Trust","doi-asserted-by":"crossref","award":["31038"],"award-info":[{"award-number":["31038"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stratified Medicine Consortium","award":["MR\/M016587\/1"],"award-info":[{"award-number":["MR\/M016587\/1"]}]},{"DOI":"10.13039\/100008392","name":"Danish Medical Research Council","doi-asserted-by":"crossref","award":["1030-00070B"],"award-info":[{"award-number":["1030-00070B"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008392","name":"Danish Medical Research Council","doi-asserted-by":"crossref","award":["4183-00118A"],"award-info":[{"award-number":["4183-00118A"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["Research project to RM"],"award-info":[{"award-number":["Research project to RM"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","award":["Lord Kelvin Adam Smith Readership"],"award-info":[{"award-number":["Lord Kelvin Adam Smith Readership"]}],"id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["HUNTER"],"award-info":[{"award-number":["HUNTER"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"crossref","award":["R167-A10784"],"award-info":[{"award-number":["R167-A10784"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"crossref","award":["R278-A16638"],"award-info":[{"award-number":["R278-A16638"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"crossref","award":["R98-A6446"],"award-info":[{"award-number":["R98-A6446"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","award":["318434"],"award-info":[{"award-number":["318434"]}],"id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","award":["320463"],"award-info":[{"award-number":["320463"]}],"id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"MICINN","doi-asserted-by":"crossref","award":["PID2019-105378RB-I00"],"award-info":[{"award-number":["PID2019-105378RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["MR\/M016587\/1"],"award-info":[{"award-number":["MR\/M016587\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["COST Action CA18122 European Cholangiocarcinoma Ne"],"award-info":[{"award-number":["COST Action CA18122 European Cholangiocarcinoma Ne"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Salut de Cataluna","award":["BECA_ACADEMIA21_001"],"award-info":[{"award-number":["BECA_ACADEMIA21_001"]}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research-UK","doi-asserted-by":"crossref","award":["CRUK Scotland Cancer Centre"],"award-info":[{"award-number":["CRUK Scotland Cancer Centre"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundaci\u00f3n MERCK Salud","award":["PI21\/01619"],"award-info":[{"award-number":["PI21\/01619"]}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23408"],"award-info":[{"award-number":["23408"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC 2019"],"award-info":[{"award-number":["AIRC 2019"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish National Health","award":["MICINN, PID2019-105378RB-I00"],"award-info":[{"award-number":["MICINN, PID2019-105378RB-I00"]}]},{"name":"European Union\u2013 NextGenerationEU","award":["NRR M4C2-Investimento 1.4- CN00000041"],"award-info":[{"award-number":["NRR M4C2-Investimento 1.4- CN00000041"]}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"crossref","award":["SGR-1358"],"award-info":[{"award-number":["SGR-1358"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["0058419"],"award-info":[{"award-number":["0058419"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["0074956"],"award-info":[{"award-number":["0074956"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["RO1DK128289"],"award-info":[{"award-number":["RO1DK128289"]}]},{"name":"NIH","award":["RO1DK56621"],"award-info":[{"award-number":["RO1DK56621"]}]},{"DOI":"10.13039\/cancer","name":"Scotland Cancer Centre","doi-asserted-by":"publisher","award":["Hepato-Biliary Theme (315960-02)"],"award-info":[{"award-number":["Hepato-Biliary Theme (315960-02)"]}],"id":[{"id":"10.13039\/cancer","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2023,9,11]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Cytotoxic agents are the cornerstone of treatment for patients with advanced intrahepatic cholangiocarcinoma (iCCA), despite heterogeneous benefit. We hypothesised that the pretreatment molecular profiles of diagnostic biopsies can predict patient benefit from chemotherapy and define molecular bases of innate chemoresistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We identified a cohort of advanced iCCA patients with comparable baseline characteristics who diverged as extreme outliers on chemotherapy (survival &lt;6 m in rapid progressors, RP; survival &gt;23 m in long survivors, LS). Diagnostic biopsies were characterised by digital pathology, then subjected to whole-transcriptome profiling of bulk and geospatially macrodissected tissue regions. Spatial transcriptomics of tumour-infiltrating myeloid cells was performed using targeted digital spatial profiling (GeoMx). Transcriptome signatures were evaluated in multiple cohorts of resected cancers. Signatures were also characterised using in vitro cell lines, in vivo mouse models and single cell RNA-sequencing data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pretreatment transcriptome profiles differentiated patients who would become RPs or LSs on chemotherapy. Biologically, this signature originated from altered tumour-myeloid dynamics, implicating tumour-induced immune tolerogenicity with poor response to chemotherapy. The central role of the liver microenviroment was confrmed by the association of the RPLS transcriptome signature with clinical outcome in iCCA but not extrahepatic CCA, and in liver metastasis from colorectal cancer, but not in the matched primary bowel tumours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The RPLS signature could be a novel metric of chemotherapy outcome in iCCA. Further development and validation of this transcriptomic signature is warranted to develop precision chemotherapy strategies in these settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2023-330748","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T13:22:26Z","timestamp":1695820946000},"page":"496-508","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy"],"prefix":"10.1136","volume":"73","author":[{"given":"Colm J","family":"O'Rourke","sequence":"first","affiliation":[{"name":"Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Department of Health and Medical Sciences, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Salati","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy"},{"name":"Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Rae","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8570-2519","authenticated-orcid":false,"given":"Guido","family":"Carpino","sequence":"additional","affiliation":[{"name":"Department of Anatomical, Histological, Forensic Medicine and Orthopaedic Sciences, Sapienza University of Rome, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Leslie","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pea","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G","family":"Prete","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca R","family":"Bonetti","sequence":"additional","affiliation":[{"name":"Division of Pathology, University of Modena and Reggio Emilia, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Amato","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Montal","sequence":"additional","affiliation":[{"name":"Cancer Biomarkers Research Group, Department of Medical Oncology, Hospital Universitari Arnau de Vilanova, Lleida, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosie","family":"Upstill-Goddard","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Nixon","sequence":"additional","affiliation":[{"name":"Cancer Research UK Beatson Cancer Research Institute, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Sanchon-Sanchez","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Kunderfranco","sequence":"additional","affiliation":[{"name":"Bioinformatics Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9000-611X","authenticated-orcid":false,"given":"Daniela","family":"Sia","sequence":"additional","affiliation":[{"name":"Liver Cancer Translational Research Laboratory, BCLC Group, Liver Unit and Pathology Department, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Gaudio","sequence":"additional","affiliation":[{"name":"Department of Anatomical, Histological, Forensic Medicine and Orthopaedic Sciences, Sapienza University of Rome, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-8903","authenticated-orcid":false,"given":"Diletta","family":"Overi","sequence":"additional","affiliation":[{"name":"Department of Anatomical, Histological, Forensic Medicine and Orthopaedic Sciences, Sapienza University of Rome, Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-7202","authenticated-orcid":false,"given":"Stefano","family":"Cascinu","sequence":"additional","affiliation":[{"name":"Medical Oncology, IRCCS Humanitas Research Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3832-2737","authenticated-orcid":false,"given":"Dan","family":"Hogdall","sequence":"additional","affiliation":[{"name":"Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Department of Health and Medical Sciences, Copenhagen, Denmark"},{"name":"Department of Oncology, Herlev Hospital, Herlev, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Pugh","sequence":"additional","affiliation":[{"name":"Addenbrooke's Hospital, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-8767","authenticated-orcid":false,"given":"Enric","family":"Domingo","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N","family":"Primrose","sequence":"additional","affiliation":[{"name":"Surgery, University of Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bridgewater","sequence":"additional","affiliation":[{"name":"Department of Oncology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Spallanzani","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Gelsomino","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M","family":"Llovet","sequence":"additional","affiliation":[{"name":"Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Cl\u00ednic, University of Barcelona, Barcelona, Spain"},{"name":"Icahn School of Medicine at Mount Sinai, New York, New York, USA"},{"name":"Instituci\u00f3 Catalana de Recerca i Estudis Avan\u00e7ats (ICREA), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego F","family":"Calvisi","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Regensburg Faculty of Medicine, Regensburg, Germany"},{"name":"Medical, Surgical, and Clinical Sciences, University of Sassari, Sassari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7954-6705","authenticated-orcid":false,"given":"Luke","family":"Boulter","sequence":"additional","affiliation":[{"name":"MRC HGU, The University of Edinburgh MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK"},{"name":"CRUK Scotland Cancer Centre, Glasgow-Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Caputo","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0561-7902","authenticated-orcid":false,"given":"Ana","family":"Lleo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Milan, Italy"},{"name":"Internal Medicine and Hepatology Unit, Department of Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel B","family":"Jamieson","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Glasgow, Glasgow, UK"},{"name":"CRUK Scotland Cancer Centre, Glasgow-Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Luppi","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dominici","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-5244","authenticated-orcid":false,"given":"Jesper B","family":"Andersen","sequence":"additional","affiliation":[{"name":"Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Department of Health and Medical Sciences, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4835-1259","authenticated-orcid":false,"given":"Chiara","family":"Braconi","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, University of Glasgow, Glasgow, UK"},{"name":"CRUK Scotland Cancer Centre, Glasgow-Edinburgh, UK"},{"name":"Beatson West of Scotland Cancer Centre, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"2025121300532590000_73.3.496.1","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jhep.2019.08.033","article-title":"\u201cReply to: \"global trends in mortality from Intrahepatic and extrahepatic cholangiocarcinoma\"\u201d","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J Hepatol"},{"key":"2025121300532590000_73.3.496.2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"key":"2025121300532590000_73.3.496.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.12.010"},{"key":"2025121300532590000_73.3.496.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721"},{"key":"2025121300532590000_73.3.496.5","doi-asserted-by":"crossref","unstructured":"Oh D-Y , Ruth He A , Qin S , et al . Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evidence 2022;1. doi:10.1056\/EVIDoa2200015","DOI":"10.1056\/EVIDoa2200015"},{"key":"2025121300532590000_73.3.496.6","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"key":"2025121300532590000_73.3.496.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00027-9"},{"key":"2025121300532590000_73.3.496.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30915-X"},{"key":"2025121300532590000_73.3.496.9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/bjc.2016.64","article-title":"Quality of life, long-term survivors and long-term outcome from the ABC-02 study","volume":"114","author":"Bridgewater","year":"2016","journal-title":"Br J Cancer"},{"key":"2025121300532590000_73.3.496.10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/bjc.2016.83","article-title":"Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy","volume":"114","author":"Moriwaki","year":"2016","journal-title":"Br J Cancer"},{"key":"2025121300532590000_73.3.496.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30109-1"},{"key":"2025121300532590000_73.3.496.12","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jamaoncol.2021.3836","article-title":"Final overall survival efficacy results of Ivosidenib for patients with advanced cholangiocarcinoma with IDH1 Mutation","volume":"7","author":"Zhu","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025121300532590000_73.3.496.13","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.2217\/fon-2020-0429","article-title":"FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 Rearrangements","volume":"16","author":"Bekaii-Saab","year":"2020","journal-title":"Future Oncol"},{"key":"2025121300532590000_73.3.496.14","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1158\/1078-0432.CCR-21-2384","article-title":"ESMO scale for clinical actionability of molecular targets driving targeted treatment in patients with Cholangiocarcinoma","volume":"28","author":"Verdaguer","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2025121300532590000_73.3.496.15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/onco.13844","article-title":"Comparative genomic analysis of Intrahepatic cholangiocarcinoma: biopsy type, ancestry, and testing patterns","volume":"26","author":"Israel","year":"2021","journal-title":"Oncologist"},{"key":"2025121300532590000_73.3.496.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.10.015"},{"key":"2025121300532590000_73.3.496.17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.annonc.2022.05.522","article-title":"Whole-genome and transcriptome analysis enhances precision cancer treatment options","volume":"33","author":"Pleasance","year":"2022","journal-title":"Ann Oncol"},{"key":"2025121300532590000_73.3.496.18","doi-asserted-by":"crossref","first-page":"101955","DOI":"10.1016\/j.clinre.2022.101955","article-title":"Multicentre match-paired analysis of advanced biliary cancer long-term survivors: the BILONG study","volume":"46","author":"Caputo","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2025121300532590000_73.3.496.19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31092"},{"key":"2025121300532590000_73.3.496.20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326514"},{"key":"2025121300532590000_73.3.496.21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.30816","article-title":"Identification of a pan-gamma-secretase inhibitor response signature for notch-driven cholangiocarcinoma","volume":"71","author":"O\u2019Rourke","year":"2020","journal-title":"Hepatology"},{"key":"2025121300532590000_73.3.496.22","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312278"},{"key":"2025121300532590000_73.3.496.23","doi-asserted-by":"crossref","unstructured":"Affo S , Nair A , Brundu F , et al . Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell 2021;39. doi:10.1016\/j.ccell.2021.05.010","DOI":"10.1016\/j.ccell.2021.05.010"},{"key":"2025121300532590000_73.3.496.24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092854","article-title":"Molecular profiling in daily clinical practice: practicalities in advanced cholangiocarcinoma and other biliary tract cancers","volume":"9","author":"Lamarca","year":"2020","journal-title":"J Clin Med"},{"key":"2025121300532590000_73.3.496.25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0837"},{"key":"2025121300532590000_73.3.496.26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s13238-015-0237-2","article-title":"G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers","volume":"7","author":"Li","year":"2016","journal-title":"Protein Cell"},{"key":"2025121300532590000_73.3.496.27","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cmet.2019.02.001","article-title":"Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer","volume":"29","author":"Halbrook","year":"2019","journal-title":"Cell Metab"},{"key":"2025121300532590000_73.3.496.28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jhep.2022.05.043","article-title":"Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target","volume":"77","author":"Alvisi","year":"2022","journal-title":"J Hepatol"},{"key":"2025121300532590000_73.3.496.29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-326928"},{"key":"2025121300532590000_73.3.496.30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1158\/1078-0432.CCR-22-1630","article-title":"Addition of losartan to FOLFIRINOX and chemoradiation reduces immunosuppression-associated genes, Tregs, and Foxp3+ cancer cells in locally advanced pancreatic cancer","volume":"29","author":"Boucher","year":"2023","journal-title":"Clinical Cancer Research"},{"key":"2025121300532590000_73.3.496.31","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2700"},{"key":"2025121300532590000_73.3.496.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00153-7"},{"key":"2025121300532590000_73.3.496.33","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325808"},{"key":"2025121300532590000_73.3.496.34","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.12.005"},{"key":"2025121300532590000_73.3.496.35","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3375"},{"key":"2025121300532590000_73.3.496.36","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0368"},{"key":"2025121300532590000_73.3.496.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.12.006"},{"key":"2025121300532590000_73.3.496.38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.001"},{"key":"2025121300532590000_73.3.496.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.008"},{"key":"2025121300532590000_73.3.496.40","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/hep.31862","article-title":"Molecular characterization of biliary tract cancer predicts chemotherapy and programmed death 1\/programmed death-ligand 1 blockade responses","volume":"74","author":"Yoon","year":"2021","journal-title":"Hepatology"},{"key":"2025121300532590000_73.3.496.41","doi-asserted-by":"publisher","DOI":"10.1038\/nature23306"},{"key":"2025121300532590000_73.3.496.42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s43018-020-0050-6","article-title":"Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes","volume":"1","author":"Pleasance","year":"2020","journal-title":"Nat Cancer"},{"key":"2025121300532590000_73.3.496.43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1470-2045(19)30798-3","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (new EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial","volume":"21","author":"Bridgewater","year":"2020","journal-title":"Lancet Oncol"},{"key":"2025121300532590000_73.3.496.44","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1038\/s41388-021-01960-w","article-title":"Hypoxic exosomal HIF-1Alpha-stabilizing CircZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing Glycolysis","volume":"40","author":"Zeng","year":"2021","journal-title":"Oncogene"},{"key":"2025121300532590000_73.3.496.45","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41388-021-02148-y","article-title":"The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity","volume":"41","author":"Lin","year":"2022","journal-title":"Oncogene"},{"key":"2025121300532590000_73.3.496.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.03.038"},{"key":"2025121300532590000_73.3.496.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1131-x"},{"key":"2025121300532590000_73.3.496.48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor Microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"2025121300532590000_73.3.496.49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-330748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:53:40Z","timestamp":1765616020000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-330748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2,23]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/gutjnl-2023-330748"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-330748","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]}}}